(Q50161287)

26 February 2018

title

Prevention of colorectal cancer: a cost-effectiveness approach to a screening model employing sigmoidoscopy. (English)

1 reference

26 February 2018

1 reference

1 reference

J Norum

1

1 reference

26 February 2018

publication date

1 June 1998

1 reference

26 February 2018

published in

Annals of Oncology

1 reference

26 February 2018

volume

9

1 reference

26 February 2018

issue

6

1 reference

26 February 2018

page(s)

613-618

1 reference

26 February 2018

Screening for colorectal cancer

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

Colorectal cancer screening: clinical guidelines and rationale

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

Polypectomy of adenomas in the prevention of colorectal cancer: 10 years' follow-up of the Telemark Polyp Study I. A prospective, controlled population study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

Cost-effectiveness model for colon cancer screening

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

Colorectal cancer screening

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

Prevention of colorectal cancer by once-only sigmoidoscopy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

Treatment costs in Hodgkin's disease: a cost-utility analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

Cost benefit of early diagnosis of colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

Natural history of untreated colonic polyps.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

The yield of a second screening flexible sigmoidoscopy in average-risk persons after one negative examination

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

Adjuvant chemotherapy (5-fluorouracil and levamisole) in Dukes' B and C colorectal carcinoma. A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

A cost-effectiveness approach to the Norwegian follow-up programme in colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

Mass screening for colorectal cancer: are we ready?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

Is it time to recommend screening for colorectal cancer?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008232729664

7 January 2021

Identifiers

DOI

10.1023/A:1008232729664

1 reference

26 February 2018

1 reference

26 February 2018